Satellos Bioscience Inc. (MSLE) vs Polyrizon Ltd. (PLRZ)

A side-by-side comparison of Satellos Bioscience Inc. and Polyrizon Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MSLE

Satellos Bioscience Inc.

$10M

$8.12HealthcareDelayed quote: Oct 6, 2026, 12:10 PM EDT

PLRZ

Polyrizon Ltd.

$10M

$9.35HealthcareDelayed quote: Oct 6, 2026, 12:12 PM EDT

Total return — MSLE vs PLRZ

growth of $100 · dividends reinvested · last 1y

MSLE +13.7% (+13.7%/yr)PLRZ -32.6% (-32.6%/yr)MSLE compounded faster over this window

MSLE PLRZ

Metrics side by side

Total return (annualized)

Metric	MSLE	PLRZ
Total return (1Y)	N/A	41.36%

PLRZ is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full MSLE analysis Full PLRZ analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.